1. Home
  2. RCUS vs TIPT Comparison

RCUS vs TIPT Comparison

Compare RCUS & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • TIPT
  • Stock Information
  • Founded
  • RCUS 2015
  • TIPT 2007
  • Country
  • RCUS United States
  • TIPT United States
  • Employees
  • RCUS N/A
  • TIPT N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • TIPT Property-Casualty Insurers
  • Sector
  • RCUS Health Care
  • TIPT Finance
  • Exchange
  • RCUS Nasdaq
  • TIPT Nasdaq
  • Market Cap
  • RCUS 727.1M
  • TIPT 865.4M
  • IPO Year
  • RCUS 2018
  • TIPT 2007
  • Fundamental
  • Price
  • RCUS $7.88
  • TIPT $22.51
  • Analyst Decision
  • RCUS Strong Buy
  • TIPT
  • Analyst Count
  • RCUS 10
  • TIPT 0
  • Target Price
  • RCUS $29.50
  • TIPT N/A
  • AVG Volume (30 Days)
  • RCUS 1.2M
  • TIPT 227.7K
  • Earning Date
  • RCUS 05-07-2025
  • TIPT 04-30-2025
  • Dividend Yield
  • RCUS N/A
  • TIPT 1.38%
  • EPS Growth
  • RCUS N/A
  • TIPT 289.39
  • EPS
  • RCUS N/A
  • TIPT 1.30
  • Revenue
  • RCUS $258,000,000.00
  • TIPT $2,042,854,000.00
  • Revenue This Year
  • RCUS N/A
  • TIPT N/A
  • Revenue Next Year
  • RCUS $25.77
  • TIPT N/A
  • P/E Ratio
  • RCUS N/A
  • TIPT $17.32
  • Revenue Growth
  • RCUS 120.51
  • TIPT 23.88
  • 52 Week Low
  • RCUS $6.50
  • TIPT $15.52
  • 52 Week High
  • RCUS $18.98
  • TIPT $26.90
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 44.26
  • TIPT 50.15
  • Support Level
  • RCUS $6.75
  • TIPT $20.30
  • Resistance Level
  • RCUS $8.36
  • TIPT $23.19
  • Average True Range (ATR)
  • RCUS 0.60
  • TIPT 1.37
  • MACD
  • RCUS 0.16
  • TIPT -0.09
  • Stochastic Oscillator
  • RCUS 74.19
  • TIPT 53.00

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

Share on Social Networks: